• 54,610+ CME Conference Registrations Sold
  • 163,830+ Medical Conferences
  • 284 Specialties
  • 11,703 Organizers
  • 159,389 Speakers
  • 159 Countries
  • 4,842 Cities
Duration: CME/CE Points: Faculty:
-
CME : 19

88th European Atherosclerosis Society (EAS) Congress will be organized by the European Atherosclerosis Society (EAS), Kenes Group. This Online CME conference will be held from Oct 04 - 07, 2020.

Who should attend?
The 88th European Atherosclerosis Society Congress is the global meeting place for specialists in the field of clinical chemistry, diabetes, endocrinology, primary care as well as clinicians and basic researchers studying atherosclerosis and related vascular diseases. Because of the diverse, clinically focused educational offering, participants are able to tailor the curriculum to meet the needs of international clinicians of all levels of experience.

How many CME credits can be earned from EAS 2020 CME webcast?

Accreditation Statement and Credit Designation

European Accreditation Council for Continuing Medical Education (UEMS/EACCME)

The 88th European Atherosclerosis Society Congress is authorized by the European Accreditation Council for Continuing Medical Education (EACCME) to present the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.net.

The 88th European Atherosclerosis Society Congress is assigned for a maximum of, or up to 19 European external CME credits. Each medical specialist should acquire only those hours of credit that he/she actually spent in the educational activity.

What are the topics addressed in EAS 2020 CME webcast?

Topics:
Pathogenesis of Atherosclerosis
• Endothelial Cell Function and Biology
• Smooth Muscle Cell Biology
• Macrophages in Lipid Metabolism and Atherosclerosis
• Inflammation, Immunity and Infection in Atherosclerosis
• Extracellular Matrix and Calcification
• Hormones and Atherosclerosis
• Vascular Biology of the Arterial Wall: Miscellaneous
• Atherosclerosis Regression
• Imaging Technology

Lipids and Lipoproteins
• Lp(a)
• TG Rich Lipoproteins Metabolism and Lipases
• HDL
• Lipoprotein Receptors
• Bile Acids
• Cholesterol Efflux and Reverse Cholesterol Transport
• lipids Beyond Cholesterol and Triglycerides (Lipidomics)
• Cellular Lipid Metabolism and Lipid Droplets
• Lipid and Lipoprotein Metabolism: Miscellaneous
• Modified Lipoproteins

Dyslipidemia and Risk Factors
• Epidemiology of Cardiovascular Diseases and Risk Factors
• Epidemiology of Dyslipidemias
• Diabetes, Insulin Sensitivity and Resistance
• Adipose Tissue Homeostasis
• Inherited Dyslipidemias
• Gender and Cardiovascular Risk
• Environmental Risk Factors
• Novel Risk Factors and Biomarkers
• Epidemiology of Socioeconomic and Psychosocial Risk Factors
• Coagulation
• Gut Microbiome
• Gene Editing Technology
• Genomics, GWAS and Population Genetics; Mendelian Randomization
• Epigenetics and Microrna
• Gene-environment Interactions

Clinical Vascular Disease
• Coagulation and Thrombosis
• Endothelial Dysfunction; Clinical Assessment
• Nash and Other Ectopic Lipid Diseases
• Chronic Kidney Disease and Nephropathies
• Diabetes; Macro- and Microangiopathies
• Aneurysms and Other Non-atherosclerotic Arteriopathies
• Nutrition, Nutraceuticals
• Bariatric Surgery
• Lipid-lowering Therapies
• Anti-thrombotic Therapies
• Anti-inflammatory Therapies
• Prevention and Treatment of Cardiovascular disease; Miscellaneous
• New Lipid Lowering Therapies

What are the objectives of the EAS 2020 CME webcast?

Course Objectives 
At the conclusion of this CME webcast participants should be able to:  
•  Discuss individual inadequacies in compliance with their Continuous Professional Development (CPD) plan.
•  Review novel treatment approaches to atherosclerosis around the world.
•  Review the new therapeutic approaches to atherosclerotic vascular disease.
•  Share ideas and knowledge in the field of atherosclerosis and related cardiovascular conditions across continents, institutions, and individuals.
•  Examine the latest scientific advantages in the field of atherosclerosis and related cardiovascular conditions.
•  Recognize the foundations of Immunometabolism and implications for metabolic health and disease.
•  Explain the prevailing research projects within EAS and enhance opportunities for future collaboration between groups of young researchers.
•  Recognize educational resources and networks for the exchange of knowledge and learning about atherosclerosis.

Intended Audience

Cardiology, Vascular Disease

Fees

Activity Fee : Fee Details will be updated soon
Interested

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.

Recommended